Journal article

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels

Carolina Bonilla, Sarah J Lewis, Mari-Anne Rowlands, Tom R Gaunt, George Davey Smith, David Gunnell, Tom Palmer, Jenny L Donovan, Freddie C Hamdy, David E Neal, Rosalind Eeles, Doug Easton, Zsofia Kote-Jarai, Ali Amin Al Olama, Sara Benlloch, Kenneth Muir, Graham G Giles, Fredrik Wiklund, Henrik Groenberg, Christopher A Haiman Show all

International Journal of Cancer | WILEY | Published : 2016

Grants

Awarded by World Cancer Research Fund


Awarded by Cancer Research UK


Awarded by University of Bristol


Awarded by National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme


Awarded by European Community


Awarded by National Institutes of Health


Awarded by Post-Cancer GWAS initiative


Awarded by Department of Defense


Awarded by Medical Research Council


Awarded by National Institute for Health Research


Awarded by NATIONAL CANCER INSTITUTE


Funding Acknowledgements

Grant sponsor: World Cancer Research Fund; Grant number: 2011/419; Grant sponsor: Cancer Research UK; Grant number: C18281/A19169; Grant sponsor: MRC and the University of Bristol; Grant number: G0600705, MC_UU_12013/19 (to Integrative Epidemiology Unit (IEU)); Grant sponsor: Cancer Research UK; Grant number: C18281/A19169 (to Integrative Cancer Epidemiology Programme); Grant sponsor: National Institute for Health Research (NIHR) (to Bristol Biomedical Research Unit in Nutrition, which is a partnership between University Hospitals Bristol NHS Foundation Trust and the University of Bristol); Grant sponsor: National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (to ProtecT study); Grant number: HTA 96/20/99; ISRCTN20141297; Grant sponsor: European Community's Seventh Framework Programme (grant agreement no 223175); Grant number: HEALTH-F2-2009-223175) (COGS) (to PRACTICAL and the iCOGS infrastructure); Grant sponsor: Cancer Research UK; Grant numbers: C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565; Grant sponsor: National Institutes of Health; Grant number: CA128978; Grant sponsor: Post-Cancer GWAS initiative; Grant numbers: 1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative; Grant sponsor: Department of Defense; Grant number: W81XWH-10-1-0341; Grant sponsors: Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation and the Ovarian Cancer Research Fund